Pharmacotherapy For Cardiovascular
Disorder Discussion 6
Pharmacotherapy For Cardiovascular Disorder Discussion 6
Analyze the influence of patient factors on pharmacokinetic and
pharmacodynamic processes
· Analyze the impact of changes in pharmacokinetic and
pharmacodynamic processes on patient drug therapies
· Evaluate drug therapy plans for cardiovascular disorders
Cardiovascular / Respiratory Systems
CASE STUDY Assignment
Patient HM has a history of atrial fibrillation and a transient
ischemic attack (TIA). The patient has been diagnosed with type 2
diabetes, hypertension, hyperlipidemia and ischemic heart
disease. Drugs currently prescribed include the following:
• Warfarin 5 mg daily MWF and 2.5 mg daily T, TH, Sat, Sun
• Aspirin 81 mg daily
• Metformin 1000 mg po bid
• Glyburide 10 mg bid